Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case report
Open Access
- 16 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (2)
Abstract
PRKAG2 syndrome (PS) is a rare, early-onset autosomal dominant inherited disease caused by mutations in PRKAG2, the gene encoding the regulatory γ2 subunit of adenosine monophosphate-activated protein kinase. PRKAG2 syndrome is associated with many cardiac manifestations, including pre-excitation, arrhythmias, left ventricular hypertrophy, and chronotropic incompetence frequently leading to early pacemaker placement. A meta-analysis of genome-wide association data in subjects with chronic kidney disease (CKD) identified a susceptibility locus in an intron of PRKAG2, which has been replicated in other studies. However, CKD has not been reported in patients with PS or mutations in PRKAG2. We report a case of a woman diagnosed at age 27 with PS when she presented with atrial fibrillation and pre-excitation on electrocardiogram. By age 35, she had developed mild renal insufficiency and a biopsy demonstrated IgA nephropathy (IGAN). This is the first reported case of IGAN in a patient with PS. We discuss both PS and IGAN and the potential mechanisms by which they could be related.Keywords
This publication has 17 references indexed in Scilit:
- Generalization of Associations of Kidney-Related Genetic Loci to American IndiansClinical Journal of the American Society of Nephrology, 2014
- Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascadeBMC Cancer, 2013
- Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRDPLOS Genetics, 2011
- The pathogenesis of IgA nephropathyCurrent Opinion in Nephrology and Hypertension, 2011
- SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathyJournal of Molecular and Cellular Cardiology, 2010
- New loci associated with kidney function and chronic kidney diseaseNature Genetics, 2010
- Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Glycogen Storage Diseases Presenting as Hypertrophic CardiomyopathyNew England Journal of Medicine, 2005
- Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage CardiomyopathyCirculation, 2003
- Identification of a Gene Responsible for Familial Wolff–Parkinson–White SyndromeNew England Journal of Medicine, 2001